AKANG HEALTH
Akon health is an operation and management organization of prescription drugs for chronic diseases, which integrates prescription drug management, chronic disease management, hospital prescription circulation, e-commerce operation, and out-of-hospital prescription increment. It focuses on providing pharmaceutical service and care for patients with chronic diseases who leave the hospital, and providing channel expansion, product increment, and patient data management of out-of-hospital prescription drugs for pharmaceutical enterprises.
AKANG HEALTH
Industry:
Health Care Medical Pharmaceutical
Address:
Beijing, Beijing, China
Country:
China
Total Employee:
1+
Status:
Active
Total Funding:
200 M CNY
Similar Organizations
Aprea
Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Scilex Pharmaceuticals
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Investors List
CICC Qide
CICC Qide investment in Series B - Akang health
China Science and Technology Innovation
China Science and Technology Innovation investment in Series B - Akang health
Nanjing Bofu Investment
Nanjing Bofu Investment investment in Series B - Akang health
Shenzhen Weizi Wealth Fund
Shenzhen Weizi Wealth Fund investment in Series B - Akang health